Published • loading... • Updated
Onyx Scientific invests to expand commercial API manufacturing capacity
Summary by European Pharmaceutical Manufacturer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Onyx Scientific invests to expand commercial API manufacturing capacity
Onyx Scientific has announced an investment of more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities, and increase capacity for commercial active pharmaceutical ingredient (API) production at the company’s Sunderland UK facility.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
